Safety profile of phase I and II preventive HIV type 1 envelope vaccination: Experience of the NIAID AIDS Vaccine Evaluation Group

AIDS Research and Human Retroviruses

Volumn 13, Issue 14, 1997, Pages 1163-1177

  Keefer, M C ^a   Wolff, M ^a   Gorse, G J ^a   Graham, B S ^a   Corey, L ^a   Clements Mann, M L ^a   Verani Ketter, N ^a   Erb, S ^a   Smith, C M ^a   Belshe, R B ^a   Wagner, L J ^a   McElrath, M J ^a   Schwartz, D H ^a   Fast, P ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL TRIAL; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; VACCINATION;

EID: 0030967937     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.1163     Document Type: Article

References (66)